KR20220121544A - Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component - Google Patents
Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component Download PDFInfo
- Publication number
- KR20220121544A KR20220121544A KR1020210025759A KR20210025759A KR20220121544A KR 20220121544 A KR20220121544 A KR 20220121544A KR 1020210025759 A KR1020210025759 A KR 1020210025759A KR 20210025759 A KR20210025759 A KR 20210025759A KR 20220121544 A KR20220121544 A KR 20220121544A
- Authority
- KR
- South Korea
- Prior art keywords
- blackcurrant
- flight
- extract
- antibacterial
- skin
- Prior art date
Links
- 235000001466 Ribes nigrum Nutrition 0.000 title claims abstract description 76
- 239000000284 extract Substances 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 11
- 235000016954 Ribes hudsonianum Nutrition 0.000 title claims description 73
- 240000001890 Ribes hudsonianum Species 0.000 title claims description 60
- 230000001153 anti-wrinkle effect Effects 0.000 title claims description 8
- 238000000338 in vitro Methods 0.000 title abstract description 4
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 30
- 241000588724 Escherichia coli Species 0.000 claims abstract description 18
- 241000222122 Candida albicans Species 0.000 claims abstract description 15
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims abstract description 15
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 229940095731 candida albicans Drugs 0.000 claims abstract description 11
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 239000002537 cosmetic Substances 0.000 claims description 16
- 230000006872 improvement Effects 0.000 claims description 16
- 235000013376 functional food Nutrition 0.000 claims description 14
- 230000036541 health Effects 0.000 claims description 13
- 230000037303 wrinkles Effects 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- 241001312569 Ribes nigrum Species 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 9
- 230000009467 reduction Effects 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000037331 wrinkle reduction Effects 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 11
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- 230000007760 free radical scavenging Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- -1 pack Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 4
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000001974 tryptic soy broth Substances 0.000 description 4
- 108010050327 trypticase-soy broth Proteins 0.000 description 4
- 229940015975 1,2-hexanediol Drugs 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 229960005305 adenosine Drugs 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000003617 indole-3-acetic acid Substances 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 238000010159 Duncan test Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- OHDRQQURAXLVGJ-AXMZSLBLSA-N azane;(2z)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-AXMZSLBLSA-N 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- JPCBEVHCIJLZFV-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO.CCCCC(O)CO JPCBEVHCIJLZFV-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000007395 thrombosis prophylaxis Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 항산화 활성을 가지는 블랙커런트 기내배양묘 추출물을 유효성분으로 함유하는 항균 및 피부 주름개선용 조성물에 관한 것이다.The present invention relates to an antibacterial and anti-wrinkle composition comprising, as an active ingredient, an extract of in-flight cultured black currant seedlings having antioxidant activity.
광노화(photoaging)란, 자외선에 의해 피부에 주름이 생기는 현상을 말하는 것으로, 피부가 거칠어지고 탄력이 떨어지며 건조해지고 주근깨, 기미, 잡티와 같은 색소 침착이 일어나기도 하며, 피부의 모세 혈관이 늘어나 피부가 붉어지기도 한다. 광노화에 의하 피부 주름은 피부의 주요 구성성분인 콜라겐(collagen)의 함량이 감소하여 더욱 쉽게 형성된다고 알려져 있다. 콜라겐 감소에 큰 영향을 미치는 것은 콜라겐 분해 효소(MMPs;matrix metalloproteinases)로, 이는 세포외기질(extracellular matrix)과 기저막(basement membrane)의 분해에 관여한다. MMP 효소는 자외선에 의해 활성이 증가하며 이를 억제함으로써 자외선에 의해 유도되는 피부 두께 증가 및 주름 형성이 감소된다는 연구 결과들이 보고되고 있다. Photoaging refers to the phenomenon of wrinkles on the skin caused by ultraviolet rays, and the skin becomes rough, loses elasticity, becomes dry, and pigmentation such as freckles, blemishes, and blemishes occurs, and the capillaries of the skin increase and the skin becomes thinner. may be red It is known that skin wrinkles due to photoaging are more easily formed because the content of collagen, which is a major component of the skin, decreases. Collagen degrading enzymes (MMPs; matrix metalloproteinases) have a major influence on the reduction of collagen, which is involved in the decomposition of extracellular matrix and basement membrane. MMP enzyme activity is increased by ultraviolet rays, and by inhibiting it, research results have been reported that increase in skin thickness and reduce wrinkles induced by ultraviolet rays.
한편, 피부 표면에 존재하는 그람 양성의 구균은 피부염의 핵심 증상인 습진을 유발하는데, 대표적으로 황색포도상구균(Staphylococcus aureus)을 들 수 있다. 또한, 세균 못지않게 정상 피부에 존재하는 진균도 피부염 발생에 영향을 주는 것으로 알려져 있다. 피부염 때문에 피부를 긁어서 피부 장벽이 손상되면 진균이 피부를 뚫고 침투하여 면역반응을 유발할 수 있으며, 이러한 면역반응이 피부염의 악화인자로 작용할 수 있다. 칸디다(Candida)균은 불완전균아문 진균류의 한 속으로 단세포의 구형 또는 난원형이며, 인체나 동물의 입안, 피부 등에 존재하여 정상상태에서는 인체에 무해하나 항생물질을 장기 사용하거나 인체가 면역에 대한 저항력이 약해졌을 때에 체내에서 이상번식을 하여 칸디다증을 일으킨다. 감염빈도가 높은 부위는 입안과 음부(陰部) 등의 점막으로, 점막이 짓무르는 가려움이나 통증이 일어난다. 이를 치료하는 약물로 스테로이드제와 항염제, 항균항생물질 등이 사용되고 있으나 이 약물들은 독성이 심하고 장기적으로 사용시 여러 가지 부작용이 나타난다. On the other hand, Gram-positive cocci present on the skin surface cause eczema, which is a key symptom of dermatitis, typically Staphylococcus aureus . In addition, it is known that fungi present in normal skin as well as bacteria affect the occurrence of dermatitis. When the skin barrier is damaged by scratching the skin due to dermatitis, the fungus can penetrate the skin and trigger an immune response, which can act as an exacerbation factor for dermatitis. Candida is a genus of fungi of the subphylum Imperfecta. It is a single-celled spherical or oval-shaped, present in the mouth and skin of the human body or animal. It is harmless to the human body under normal conditions. When this is weakened, it reproduces abnormally in the body, causing candidiasis. Areas with a high frequency of infection are mucous membranes such as the mouth and genitals, which cause itching or pain. Steroids, anti-inflammatory drugs, and antibacterial and antibiotics are used as drugs to treat it, but these drugs are highly toxic and have various side effects when used for a long time.
한편, 블랙커런트(Black currant, Ribes nigrum)는 중앙 북부 유럽과 히말라야 지역이 원산지인 낙엽 활엽관목으로, 키가 1~2m 정도로 자라는 식물이다. 블랙커런트의 잎은 길이와 폭이 3~5㎝ 정도이고, 3~5개로 갈라지고 불규칙한 거치가 있으며, 잎 표면에 털이 없고 뒷면에는 점이 산재하며, 잎과 줄기에 향이 있다. 블랙커런트의 꽃은 직경이 4~6mm 정도이고 녹조 홍색을 띠고 있으며, 5~10cm 길이의 총상화서에 달려 있다. 블랙커런트의 열매는 7~8월에 익으며, 직경은 1cm 정도이고, 표면은 윤기가 나고 익으면 흑색에 가까운 군청색을 띤다. 블랙커런트는 수세기에 걸쳐 식용 및 영양식품으로 이용되어 왔다. 북유럽에서는 고대로부터 블랙커런트를 식용과일로 섭취하여 왔다. 중세인 16세기부터는 약초로 사용되어왔는데, 약초학자들은 블랙커런트를 방광결석의 치료에 사용하여 왔고, 블랙커런트를 시럽으로 만들어서 감기 및 호흡기 질환에 사용하여 왔던 것으로 알려져 있다.On the other hand, black currant (Black currant, Ribes nigrum ) is a deciduous broad-leaved shrub native to central northern Europe and the Himalayas, and is a plant that grows to about 1 to 2 m in height. The leaves of black currant are about 3-5 cm in length and width, are split into 3-5 parts and have irregular serrations, have no hair on the surface of the leaves, and spots are scattered on the back, and the leaves and stems are fragrant. The flowers of black currant are about 4-6mm in diameter and have a green algae red color, and hang on raceme 5-10cm long. The fruits of black currant ripen in July-August, and the diameter is about 1cm, and the surface is shiny and has a dark blue color close to black when ripe. Blackcurrants have been used as an edible and nutritious food for centuries. In Northern Europe, black currant has been consumed as an edible fruit since ancient times. It has been used as a medicinal herb since the 16th century in the Middle Ages, and herbalists have been using blackcurrant to treat bladder stones, and it is known that blackcurrant has been used as a syrup for colds and respiratory diseases.
한편, 한국등록특허 제2184823호에는 '블랙커런트, 링곤베리 및 씨벅손 추출물을 포함하는 항산화 조성물'이 개시되어 있고, 한국등록특허 제1678301호에는 '블랙커런트 열매 추출물을 유효성분으로 함유하는 혈전증 예방 또는 치료용 약학적 조성물 및 건강 기능 식품'이 개시되어 있으나, 본 발명의 '항산화 활성을 가지는 블랙커런트 기내배양묘 추출물을 유효성분으로 함유하는 항균 및 피부 주름개선용 조성물'에 대해서는 기재된 바가 없다.On the other hand, Korean Patent No. 2184823 discloses 'Antioxidant composition comprising blackcurrant, lingonberry and sea buckthorn extract', and Korean Patent No. 1678301 discloses 'Thrombosis prevention containing blackcurrant fruit extract as an active ingredient' Or therapeutic pharmaceutical composition and health functional food' is disclosed, but there is no description about the 'antibacterial and skin wrinkle-improving composition containing the extract of blackcurrant in-flight cultured seedlings having antioxidant activity as an active ingredient' of the present invention.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 블랙커런트 기내배양묘 추출물의 우수한 항산화 효과를 확인하였고, 황색포도상구균(Staphlyococcus aureus), 대장균(Escherichia coli), 녹농균(Pseudomonas aeruginosa) 및 칸디다 알비칸스(Candida albicans)에 대한 항균 활성 및 MMP-1 단백질의 발현 억제 효과를 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above needs, and the present inventors confirmed the excellent antioxidant effect of the in-flight cultured blackcurrant extract, Staphlyococcus aureus , Escherichia coli , Pseudomonas aeruginosa , and Candida albicans ( Candida albicans ) By confirming the antibacterial activity and the inhibitory effect on the expression of MMP-1 protein, the present invention was completed.
상기 과제를 해결하기 위해, 본 발명은 블랙커런트 기내배양묘 추출물을 유효성분으로 함유하는 항균 및 피부 주름개선용 화장료 조성물을 제공한다. In order to solve the above problems, the present invention provides a cosmetic composition for antibacterial and anti-wrinkle improvement containing blackcurrant in-flight seedling extract as an active ingredient.
또한, 본 발명은 블랙커런트 기내배양묘 추출물을 유효성분으로 함유하는 항균 및 피부 주름개선용 건강기능식품 조성물을 제공한다. In addition, the present invention provides a health functional food composition for antibacterial and anti-wrinkle improvement containing blackcurrant in-flight seedling extract as an active ingredient.
본 발명의 블랙커런트 기내배양묘 추출물은 항산화 활성을 가지며, 황색포도상구균(Staphlyococcus aureus), 대장균(Escherichia coli), 녹농균(Pseudomonas aeruginosa) 및 칸디다 알비칸스(Candida albicans)에 대한 항균 활성 및 MMP-1 단백질의 발현 억제 효과가 우수하므로, 항균 및 피부 주름개선용 조성물로 매우 유용하게 사용될 수 있을 것으로 기대된다. Blackcurrant in-flight seedling extract of the present invention has antioxidant activity, Staphlyococcus aureus ), Escherichia coli , Pseudomonas aeruginosa ) and Candida albicans ) and MMP-1 Since the protein expression inhibitory effect is excellent, it is expected to be very useful as a composition for antibacterial and skin wrinkle improvement.
도 1은 블랙커런트 기내배양묘 추출물의 인간 섬유아세포주 CCD-986SK 세포에서의 독성을 확인한 결과이다.
도 2는 블랙커런트 기내배양묘 추출물의 DPPH 자유 라디칼 소거능을 확인한 결과이다. Vit. C는 양성 대조군으로 이용한 비타민 C 이다. 도면 내 서로 다른 문자 a~e는 서로 유의미한 차이가 있다는 것을 의미하며, p<0.05이다.
도 3은 블랙커런트 기내배양묘 추출물의 ABTS 자유 라디칼 소거능을 확인한 결과이다. Vit. C는 양성 대조군으로 이용한 비타민 C 이다. 도면 내 서로 다른 문자 a~f는 서로 유의미한 차이가 있다는 것을 의미하며, p<0.05이다.
도 4는 블랙커런트 기내배양묘 추출물 처리에 따른 MMP-1 발현양을 확인한 결과이다. control은 아무것도 처리하지 않은 대조군이고, adenosine은 주름개선 성분으로 알려진 아데노신으로 양성 대조군으로 이용하였다. 도면 내 서로 다른 문자 a~d는 서로 유의미한 차이가 있다는 것을 의미하며, p<0.05이다.1 is a result confirming the toxicity of the extract of blackcurrant in-flight cultured seedlings in human fibroblast cell line CCD-986SK cells.
Figure 2 is the result of confirming the DPPH free radical scavenging ability of the blackcurrant in-flight seedling extract. Vit. C is vitamin C used as a positive control. Different letters a~e in the drawing mean that there is a significant difference from each other, and p<0.05.
3 is a result of confirming the ABTS free radical scavenging ability of the in-flight cultured seedling extract of blackcurrant. Vit. C is vitamin C used as a positive control. Different letters a to f in the drawing mean that there is a significant difference from each other, and p<0.05.
4 is a result of confirming the expression level of MMP-1 according to the black currant in-flight seedling extract treatment. The control was a control group that was not treated with anything, and adenosine was used as a positive control as adenosine, known as a wrinkle-improving ingredient. Different letters a to d in the drawing mean that there is a significant difference from each other, and p<0.05.
본 발명의 목적을 달성하기 위하여, 본 발명은 블랙커런트 기내배양묘 추출물을 유효성분으로 함유하는 항균 및 피부 주름개선용 화장료 조성물을 제공한다. In order to achieve the object of the present invention, the present invention provides a cosmetic composition for antibacterial and anti-wrinkle improvement containing blackcurrant in-flight seedling extract as an active ingredient.
상기 블랙커런트 기내배양묘는 바람직하게는 공동연구기관인 전남과학대로부터 분양받은 것(한국등록특허 제1836619호)이나, 이에 제한되지 않는다. The blackcurrant in-flight cultured seedlings are preferably those received from Chonnam National University of Science and Technology, a joint research institute (Korea Patent No. 1836619), but are not limited thereto.
본 발명의 블랙커런트 기내배양묘 추출물의 추출용매는 C1~C4의 저급알코올, 물 또는 이들의 혼합물인 것이 바람직하고, 보다 바람직하게는 에탄올인 것이지만, 이에 제한되지 않는다. The extraction solvent of the blackcurrant in-flight seedling extract of the present invention is preferably a C 1 to C 4 lower alcohol, water, or a mixture thereof, and more preferably ethanol, but is not limited thereto.
본 발명의 블랙커런트 기내배양묘 추출물의 추출방법은 여과법, 열수 추출, 침지 추출, 환류 냉각 추출 및 초음파 추출 등의 당업계에 공지된 모든 통상적인 방법을 이용할 수 있다. 상기 추출용매는 블랙커런트 기내배양묘 중량의 1~20배 첨가하여 추출하는 것이 바람직하며, 더 바람직하게는 5~15배 첨가하는 것이나, 이에 한정하지 않는다. 추출온도는 20~60℃인 것이 바람직하며, 더 바람직하게는 30~50℃인 것이나, 이에 한정하지 않는다. 또한, 추출시간은 4~8시간인 것이 바람직하며, 더 바람직하게는 5~7시간인 것이나, 이에 한정하지 않는다. All conventional methods known in the art, such as filtration, hot water extraction, immersion extraction, reflux cooling extraction, and ultrasonic extraction, may be used for the extraction method of the blackcurrant in-flight seedling extract of the present invention. The extraction solvent is preferably extracted by adding 1 to 20 times the weight of the in-flight cultured blackcurrant seedlings, and more preferably adding 5 to 15 times, but is not limited thereto. The extraction temperature is preferably 20 to 60 °C, more preferably 30 to 50 °C, but is not limited thereto. In addition, the extraction time is preferably 4 to 8 hours, more preferably 5 to 7 hours, but is not limited thereto.
또한, 상기 블랙커런트 기내배양묘 추출물은 추출처리에 의해 얻어지는 추출액; 추출액의 희석액 또는 농축액; 추출액을 건조하여 얻어지는 건조물; 조정제물; 또는 정제물 중 어느 하나를 포함할 수도 있다.In addition, the blackcurrant in-flight seedling extract is an extract obtained by extraction treatment; dilutions or concentrates of extracts; a dried product obtained by drying the extract; modifiers; Or it may include any one of the purified product.
본 발명의 블랙커런트 기내배양묘 추출물은 항산화 활성이 우수하고, 황색포도상구균(Staphlyococcus aureus), 대장균(Escherichia coli), 녹농균(Pseudomonas aeruginosa) 및 칸디다 알비칸스(Candida albicans)에 대한 항균 활성이 있으며, MMP-1 단백질의 발현 억제 효과가 우수하다. The blackcurrant in-flight seedling extract of the present invention has excellent antioxidant activity, and has antibacterial activity against Staphlyococcus aureus , Escherichia coli , Pseudomonas aeruginosa , and Candida albicans , The effect of inhibiting the expression of MMP-1 protein is excellent.
본 발명의 항균 및 피부 주름개선용 화장료 조성물은 크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 밀크로션, 모이스처로션, 영양로션, 마사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어지는 군으로부터 선택된 어느 하나의 제형을 가질 수 있으며, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선절될 수 있다. The cosmetic composition for antibacterial and skin wrinkle improvement of the present invention is a cream, softening lotion, nourishing lotion, pack, essence, hair tonic, shampoo, conditioner, hair conditioner, hair treatment, gel, skin lotion, skin softener, skin toner, astringent , milk lotion, moisturizing lotion, nourishing lotion, massage cream, nourishing cream, moisture cream, hand cream, foundation, nourishing essence, sunscreen, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser It may have any one selected formulation, but is not limited thereto. The cosmetic composition composed of each of these formulations may contain various bases and additives necessary and appropriate for the formulation of the formulation, and the types and amounts of these components can be easily determined by those skilled in the art.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as a carrier component etc. may be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판 부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydro It may contain a propellant such as carbon, propane butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene fatty acid esters of glycol, 1,3-butylglycol oil, glycerol aliphatic esters, polyethylene glycol or sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester; Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracanth may be used.
본 발명의 화장료 조성물의 제형이 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is surfactant-containing cleansing, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, Fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative or ethoxylated glycerol fatty acid ester and the like can be used.
또한, 본 발명은 블랙커런트 기내배양묘 추출물을 유효성분으로 함유하는 항균 및 피부 주름개선용 건강기능식품 조성물을 제공한다. In addition, the present invention provides a health functional food composition for antibacterial and anti-wrinkle improvement containing blackcurrant in-flight seedling extract as an active ingredient.
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 건강기능식품 조성물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나 건강을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로 사용될 수 있다.When the health functional food composition of the present invention is used as a food additive, the health functional food composition may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The active ingredient may be used appropriately depending on the purpose of its use (prevention or improvement). In general, in the production of food or beverage, the health functional food composition of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term intake for health purposes, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
상기 건강기능식품의 종류에 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the type of the health functional food. Examples of foods to which the health functional food composition can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, beverages, tea There are drinks, alcoholic beverages, vitamin complexes, etc., and includes all health foods in the ordinary sense.
또한, 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은 통상적으로 첨가되는 성분을 포함할 수 있다. 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.In addition, the health functional food composition of the present invention may be prepared as a food, particularly a functional food. The functional food of the present invention may include ingredients that are commonly added. Examples include proteins, carbohydrates, fats, nutrients and seasonings. For example, when manufactured as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrin, cyclodextrin, etc.) or sugar alcohols (eg, , xylitol, sorbitol, erythritol, etc.). As the flavoring agent, natural flavoring agents (eg, taumatine, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used.
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonic acid It may further contain a carbonation agent and the like used in beverages. The ratio of these added ingredients is not very important, but is generally selected in the range of 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다.Hereinafter, the present invention will be described in more detail using examples. These examples are only for illustrating the present invention in more detail, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not limited thereto.
제조예 1. 블랙커런트 기내배양묘 추출물 제조Preparation Example 1. Preparation of blackcurrant in-flight seedling extract
(1) 블랙커런트 기내배양묘의 제조(1) Preparation of in-flight cultured blackcurrant seedlings
블랙커런트 묘목에서 목질화가 진행되지 않은 가지의 어린 눈을 채취하여 계면활성제, 알코올 및 하이포아염소산나트륨(Sodium hypochlorite)을 사용하여 소독한 후 멸균수로 세척하였다. 이후, MS(Murashigae and Skoog) 기본배지 1ℓ당 수크로오스 20~50g과 파이타 겔 2~5g을 첨가한 신초형성배지에서 상기 소독된 어린 눈을, 22~27℃에서 2000~3000lux로 15~17시간 광을 조사하면서 14~21일 동안 배양하여 신초 형성을 유도하였다. 신초가 형성된 후, 신초를 마디단위로 절단한 마디신초를 MS 기본배지 1ℓ당 BAP 1~5mg을 첨가한 유묘신초배지로 옮기고 22~27℃에서 2000~3000lux로 15~17시간 광을 조사하면서 28~35일 동안 배양하여 마디유묘 증식을 유도하였다. 상기 증식된 마디유묘를 MS 기본배지 1ℓ당 BAP 0.1~3mg을 첨가한 마디유묘생장배지에서 22~27℃에서 2000~3000lux로 15~17시간 광을 조사하면서 14~21일 동안 배양하여 키와 직경을 생장시키고, MS 기본배지 1ℓ당 IBA(Indole butyric acid), NAA(1-Naphtalene acetic acid) 및 IAA(Indole acetic acid) 중 선택된 하나를 1~3mg 첨가한 발근배지에서 22~27℃에서 2000~3000lux로 15~17시간 광을 조사하면서 13~15일 동안 배양하여 발근시켰다. 이후, 발근된 유묘를 토양에 순화시켜 블랙커런트 기내배양묘를 제조하였다.Young eyes of branches that did not undergo lignification were collected from blackcurrant seedlings, disinfected using a surfactant, alcohol, and sodium hypochlorite, and then washed with sterile water. Thereafter, the sterilized young eyes in a shoot-forming medium containing 20-50 g of sucrose and 2-5 g of phyta gel per 1 liter of MS (Murashigae and Skoog) basic medium, at 22-27 ° C. at 2000-3000 lux for 15-17 hours Inducing shoot formation by culturing for 14-21 days while irradiating light. After the shoots are formed, the nodular shoots cut into nodes are transferred to the seedlings with 1~5mg of BAP per 1 liter of MS basic medium and irradiated with light at 22~27℃ at 2000~3000lux for 15~17 hours. The growth of node seedlings was induced by culturing for ~35 days. The proliferated node seedlings were cultured for 14 to 21 days while irradiating light for 15 to 17 hours at 2000 to 3000 lux at 22 to 27 ° C in a node seedling growth medium containing 0.1 to 3 mg of BAP per 1 liter of MS basal medium, followed by culturing for 14 to 21 days in height and diameter. were grown, and in a rooting medium containing 1 to 3 mg of one selected from IBA (Indole butyric acid), NAA (1-Naphtalene acetic acid) and IAA (Indole acetic acid) per 1 liter of MS basal medium, 2000~ at 22~27℃ Rooted by culturing for 13 to 15 days while irradiating light at 3000 lux for 15 to 17 hours. Then, the rooted seedlings were acclimatized to the soil to prepare blackcurrant in-flight cultured seedlings.
(2) 블랙커런트 기내배양묘 추출물의 제조(2) Preparation of black currant in-flight seedling extract
상기 방법으로 제조된 블랙커런트 기내배양묘에 70%(v/v) 에탄올을 10배수로 첨가하여 40℃에서 6시간 동안 추출한 후, 여과지로 여과하고 농축 및 동결건조하여 이후 실험에 사용하였다. 70% (v/v) ethanol was added 10 times to the blackcurrant in-flight cultured seedlings prepared by the above method, extracted at 40° C. for 6 hours, filtered with filter paper, concentrated and freeze-dried, and used for subsequent experiments.
실시예 1. 블랙커런트 기내배양묘 추출물의 세포독성 분석Example 1. Cytotoxicity analysis of blackcurrant in-flight seedling extract
인간 섬유아세포주 CCD-986SK(ATCC, CRL-1947TM)를 10% 열불활성화 소태아혈청(Heat Inactivated Fetal Bovine Serum, HIFBS)과 1% 페니실린-스트렙토마이신이 포함된 DMEM(Dulbecco Modified Eagle Medium) 배지에서 배양하였다. 96웰 플레이트에 CCD-986SK 세포를 1×104 세포/웰로 분주하고 37℃, 5% CO2 세포배양기에서 24시간 동안 배양하여 안정화한 후, 5, 10, 25, 50 및 100㎍/㎖의 블랙커런트 기내배양묘 추출물을 각 웰에 100㎕씩 넣고 24시간 배양하였다. 배양액을 제거하고 5mg/㎖의 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)를 각 웰에 넣고 2시간 동안 배양한 후, 상등액을 제거하고 DMSO(dimethyl sulfoxide)를 100 ㎕씩 분주하여 각 웰에 생성된 결정체를 모두 용해시키고, 마이크로플레이트 리더기(Multiskan Go, Thermo Scientific, USA)를 이용하여 540 nm에서 흡광도를 측정하였고, 하기 계산식을 통해 세포생존율을 분석하였다. The human fibroblast line CCD-986SK (ATCC, CRL-1947 TM ) was cultured in Dulbecco Modified Eagle Medium (DMEM) medium containing 10% Heat Inactivated Fetal Bovine Serum (HIFBS) and 1% penicillin-streptomycin. cultured in CCD-986SK cells were seeded in a 96-well plate at 1×10 4 cells/well and cultured at 37° C., 5% CO 2 for 24 hours in a cell incubator for stabilization, followed by 5, 10, 25, 50 and 100 μg/
세포생존율(%)=[시료처리군의 흡광도/대조군의 흡광도]X100Cell viability (%) = [absorbance of sample treatment group / absorbance of control group]
그 결과, 5, 10, 25, 50 및 100㎍/㎖의 블랙커런트 기내배양묘 추출물은 인간 섬유아세포주 CCD-986SK에서 세포독성을 나타내지 않는 것을 확인하였다(도 1). As a result, it was confirmed that 5, 10, 25, 50 and 100 μg/ml of in vitro cultured blackcurrant extracts did not show cytotoxicity in the human fibroblast cell line CCD-986SK ( FIG. 1 ).
실시예 2. 블랙커런트 기내배양묘 추출물의 항산화 활성 분석Example 2. Analysis of antioxidant activity of blackcurrant in-flight seedling extract
(1) 플라보노이드(flavonoid) 함량 측정(1) Measurement of flavonoid content
동결건조한 블랙커런트 기내배양묘 추출물 1mg을 메탄올 1㎖에 녹이고 디에틸렌글리콜(diethylene glycol) 10㎖을 첨가하여 잘 혼합하고, 1N NaOH 1㎖을 첨가하여 37℃에서 1시간 동안 반응시킨 후, 420 nm에서 흡광도를 측정하였다. 이 때, 표준물질로 퀘르세틴(quercetin)을 사용하였고 시료와 동일한 방법으로 분석 후 얻은 표준곡선으로부터 총 플라보노이드 함량을 계산하였다. Dissolve 1 mg of freeze-dried blackcurrant in-flight seedling extract in 1 ml of methanol, add 10 ml of diethylene glycol, mix well, add 1 ml of 1N NaOH, and react at 37° C. for 1 hour, then 420 nm absorbance was measured. At this time, quercetin was used as a standard material, and the total flavonoid content was calculated from the standard curve obtained after analysis in the same manner as the sample.
그 결과, 블랙커런트 기내배양묘 추출물 내 총 플라보노이드 함량은 46.50±3.91㎎/g인 것을 확인하였다. As a result, it was confirmed that the total flavonoid content in the blackcurrant in-flight seedling extract was 46.50±3.91 mg/g.
(2) 폴리페놀(polyphenol) 함량 측정(2) Measurement of polyphenol content
동결건조한 블랙커런트 기내배양묘 추출물 1mg을 메탄올 1㎖에 녹이고 10배 희석하여 준비하였다. 상기 희석액 2㎖에 2배 희석한 페놀 시약(Folin-Ciocalteu's phenol reagent) 2㎖을 첨가하여 혼합한 다음 3분 동안 방치한 후 10% Na2CO3 용액 2㎖을 넣고 1시간 동안 반응시킨 후, 750 nm에서 흡광도를 측정하였다. 이 때, 표준물질은 갈릭산(gallic acid)을 사용하였고 시료와 동일한 방법으로 분석 후 얻은 표준곡선으로부터 총 폴리페놀 함량을 계산하였다. It was prepared by dissolving 1 mg of freeze-dried blackcurrant in-flight seedling extract in 1 ml of methanol and diluting 10 times. 2 ml of a 2-fold diluted phenol reagent (Folin-Ciocalteu's phenol reagent) was added to 2 ml of the diluent, mixed, and left for 3 minutes, then 2 ml of a 10% Na 2 CO 3 solution was added and reacted for 1 hour, Absorbance was measured at 750 nm. At this time, gallic acid was used as the standard material, and the total polyphenol content was calculated from the standard curve obtained after analysis in the same manner as the sample.
그 결과, 블랙커런트 기내배양묘 추출물 내 총 폴리페놀 함량은 41.35±0.07㎎/g인 것을 확인하였다. As a result, it was confirmed that the total polyphenol content in the blackcurrant in-flight seedling extract was 41.35±0.07 mg/g.
(3) DPPH 자유 라디칼 소거능 측정(3) Measurement of DPPH free radical scavenging ability
블랙커런트 기내배양묘 추출물을 25, 50, 100, 200 및 500㎍/㎖ 농도로 준비하였고, DPPH(1,1-diphenyl-2-picrylhydrazyl)를 에탄올에 용해하여 0.1mM DPPH 용액을 준비하였다. 각 농도의 블랙커런트 기내배양묘 추출물과 0.1mM DPPH 용액을 1:1로 섞어 96웰 플레이트에 처리하고 37℃에서 30분 동안 반응시킨 다음, 517 nm에서 흡광도를 측정하고 하기 계산식을 통해 DPPH 자유 라디칼 소거능을 산출하였다.Blackcurrant in-flight seedling extracts were prepared at concentrations of 25, 50, 100, 200 and 500 μg/ml, and DPPH (1,1-diphenyl-2-picrylhydrazyl) was dissolved in ethanol to prepare a 0.1 mM DPPH solution. Blackcurrant incubated seedling extract of each concentration and 0.1 mM DPPH solution were mixed 1:1, treated in a 96-well plate, reacted at 37°C for 30 minutes, absorbance was measured at 517 nm, and DPPH free radicals were calculated using the following formula. The scavenging ability was calculated.
DPPH 자유 라디칼 소거능(%) ={1-(A-B/C)×100DPPH free radical scavenging ability (%) = {1-(A-B/C)×100
A : 시료와 DPPH를 반응시킨 후의 흡광도 A: Absorbance after reacting the sample with DPPH
B : 시료와 에탄올을 반응시킨 후의 흡광도 B: Absorbance after reacting the sample with ethanol
C : 에탄올과 DPPH를 반응시킨 후의 흡광도(blank)C: Absorbance (blank) after reacting ethanol and DPPH
그 결과, 블랙커런트 기내배양묘 추출물의 DPPH 자유 라디칼 소거능은 농도 의존적으로 증가하는 것을 확인하였다(도 2). As a result, it was confirmed that the DPPH free radical scavenging activity of the blackcurrant in-flight seedling extract increased in a concentration-dependent manner (FIG. 2).
(4) ABTS 자유 라디칼 소거능 측정(4) ABTS free radical scavenging activity measurement
블랙커런트 기내배양묘 추출물을 25, 50, 100, 200 및 500㎍/㎖ 농도로 준비하였고, 7mM ABTS(2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt)와 2.4mM 과황산칼륨(potassium persulfate)을 1:1로 혼합하여 ABTS 용액을 준비하였다. 각 농도의 블랙커런트 기내배양묘 추출물과 상기 ABTS 용액을 1:1로 섞어 96웰 플레이트에 처리하고 상온에서 30분 동안 반응시킨 다음, 415 nm에서 흡광도를 측정하고 하기 계산식을 통해 ABTS 자유 라디칼 소거능을 산출하였다.Blackcurrant in-flight seedling extracts were prepared at concentrations of 25, 50, 100, 200 and 500㎍/㎖, 7mM ABTS (2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt) and 2.4 An ABTS solution was prepared by mixing mM potassium persulfate in a 1:1 ratio. Blackcurrant incubated seedling extract of each concentration and the ABTS solution were mixed 1:1, treated in a 96-well plate, reacted at room temperature for 30 minutes, absorbance was measured at 415 nm, and ABTS free radical scavenging ability was evaluated using the following formula calculated.
ABTS 라디칼 소거능(%) = [(A-B)/A]×100ABTS radical scavenging ability (%) = [(A-B)/A]×100
A: 대조군 흡광도A: control absorbance
B: 시료군 흡광도B: absorbance of sample group
그 결과, 블랙커런트 기내배양묘 추출물의 ABTS 자유 라디칼 소거능은 농도 의존적으로 증가하는 것을 확인하였다(도 3). As a result, it was confirmed that the ABTS free radical scavenging ability of the blackcurrant in-flight seedling extract increased in a concentration-dependent manner (FIG. 3).
실시예 3. 블랙커런트 기내배양묘 추출물의 항균 활성 분석Example 3. Analysis of antibacterial activity of blackcurrant in-flight seedling extract
(1) 디스크 확산법(Disc-diffusion method)에 의한 항균 활성 측정(1) Measurement of antibacterial activity by disc-diffusion method
황색포도상구균(Staphlyococcus aureus, ATCC 6538), 대장균(Escherichia coli, ATCC 9839) 또는 녹농균(Pseudomonas aeruginosa, ATCC 9027)을 TSB(tryptic soy broth) 배지에 접종하여 30~35℃의 배양기에서 18시간 동안 전배양한 후, 고체 배지에 도말하여 준비하였다. Staphlyococcus aureus ( ATCC 6538), E. coli ( Escherichia coli , ATCC 9839) or Pseudomonas aeruginosa ( ATCC 9027) was inoculated in TSB (tryptic soy broth) medium and pre-incubated at 30-35° C. for 18 hours. After culturing, it was prepared by plating on a solid medium.
멸균된 페이퍼 디스크에 블랙커런트 기내배양묘 추출물을 3㎎/디스크 및 6㎎/디스크로 점적하여 황색포도상구균(S. aureus), 대장균(E. coli) 또는 녹농균(P. aeruginosa)이 도말된 상기 고체 배지 위에 올려 놓고 30~35℃의 배양기에서 24시간 동안 배양한 후, 생육 저지환(clear zone)의 직경을 측정하여 항균 활성을 확인하였다. 방부제로 알려진 1,2-헥산디올(1,2-Hexanediol) 및 카프릴릴 글라이콜(Caprylyl glycol)을 10㎎/디스크로 준비하여 대조군으로 이용하였다. Blackcurrant in-flight seedling extract was dripped at 3 mg/disk and 6 mg/disc on a sterilized paper disk, and Staphylococcus aureus ( S. aureus ), E. coli ( E. coli ) or Pseudomonas aeruginosa ( P. aeruginosa ) was smeared above. It was placed on a solid medium and cultured for 24 hours in an incubator at 30-35° C., and then the diameter of the growth-stopping ring (clear zone) was measured to confirm the antibacterial activity. 1,2-hexanediol (1,2-Hexanediol) and caprylyl glycol, known as preservatives, were prepared at 10 mg/disc and used as a control.
그 결과, 블랙커런트 기내배양묘 추출물은 황색포도상구균(S. aureus), 대장균(E. coli) 또는 녹농균(P. aeruginosa)에 대한 항균 활성이 있음을 알 수 있었다(표 1, 2 및 3). As a result, it was found that the blackcurrant in-flight seedling extract had antibacterial activity against Staphylococcus aureus ( S. aureus ), E. coli or P. aeruginosa ( Tables 1, 2 and 3). .
(2) 최소저해농도(MIC) 측정에 의한 항균 활성 분석(2) Analysis of antibacterial activity by measuring the minimum inhibitory concentration (MIC)
황색포도상구균(Staphlyococcus aureus, ATCC 6538), 대장균(Escherichia coli, ATCC 9839) 또는 녹농균(Pseudomonas aeruginosa, ATCC 9027)을 TSB(tryptic soy broth) 배지에 접종하였고, 칸디다 알비칸스(Candida albicans, ATCC 10231)는 PDB(potato dextrose broth) 배지에 접종하여 30~35℃의 배양기에서 18시간 동안 전배양하여 준비하였다. 황색포도상구균(S. aureus), 대장균(E. coli) 또는 녹농균(P. aeruginosa)은 멸균생리식염수에 희석하였고, 칸디다 알비칸스(C. albicans)는 Tween 80을 0.05% 비율로 첨가한 멸균생리식염수에 희석하여 106/㎖의 균액을 각각 제조하여 준비하였다. Staphlyococcus aureus ( ATCC 6538), Escherichia coli ( ATCC 9839) or Pseudomonas aeruginosa ( ATCC 9027) was inoculated in TSB (tryptic soy broth) medium, Candida albicans ( Candida albicans , ATCC 10231) was inoculated in PDB (potato dextrose broth) medium and pre-cultured for 18 hours in an incubator at 30-35 ° C. Staphylococcus aureus ( S. aureus ), Escherichia coli ( E. coli ) or Pseudomonas aeruginosa ( P. aeruginosa ) was diluted in sterile physiological saline, and Candida albicans ( C. albicans ) was sterilized by adding Tween 80 at a rate of 0.05%. It was diluted in saline to prepare a bacterial solution of 10 6 /ml, respectively.
블랙커런트 기내배양묘 추출물을 2배씩 희석하여 10단계로 준비하였고, 상기 준비한 균액을 한 방울씩 각각 접종하여 25~32℃에서 1~3일 동안 배양한 후, 균주의 발육 유무를 육안으로 관찰하여 각 균에 대한 최소저해농도(minimum inhibitory concentration, MIC)를 판정하였다. The in-flight cultured seedling extract of blackcurrant was diluted two-fold and prepared in 10 steps, each inoculated dropwise with the prepared bacterial solution, cultured at 25~32℃ for 1~3 days, and then the growth of the strain was observed with the naked eye. The minimum inhibitory concentration (MIC) for each bacteria was determined.
그 결과, 블랙커런트 기내배양묘 추출물의 황색포도상구균(S. aureus) 및 녹농균(P. aeruginosa)에 대한 최소저해농도는 0.5%이고, 대장균(E. coli) 및 칸디다 알비칸스(C. albicans)에 대한 최소저해농도는 2.0%인 것을 확인하였다(표 4). As a result, the minimum inhibitory concentration against Staphylococcus aureus ( S. aureus ) and Pseudomonas aeruginosa ( P. aeruginosa ) of the blackcurrant in-flight seedling extract was 0.5%, and Escherichia coli ( E. coli ) and Candida albicans ( C. albicans ) It was confirmed that the minimum inhibitory concentration was 2.0% (Table 4).
실시예 4. 블랙커런트 기내배양묘 추출물의 피부 주름개선 활성 분석Example 4. Analysis of skin wrinkle improvement activity of blackcurrant in-flight seedling extract
기질 단백질 분해 효소인 MMP-1(matrix metalloproteinase-1)은 피부에 발현된 콜라겐 단백질을 분해하는 효소로, MMP-1의 발현양이 증가하면 피부 진피층의 콜라겐이 분해되어 주름이 생성된다. 따라서, 인간 섬유아세포주 CCD-986SK에 자외선을 조사한 후, 각 시료를 처리하고 MMP-1의 발현양을 측정하여 피부 주름개선 활성을 분석하였다. Matrix metalloproteinase-1 (MMP-1) is an enzyme that degrades collagen protein expressed in the skin. When the expression level of MMP-1 increases, collagen in the dermal layer of the skin is decomposed and wrinkles are generated. Therefore, after irradiating the human fibroblast line CCD-986SK with UV light, each sample was treated and the expression level of MMP-1 was measured to analyze the skin wrinkle improvement activity.
60mm 플레이트에 CCD-986SK 세포를 4×105 세포/플레이트로 분주하고 37℃, 5% CO2 배양기에서 24시간 동안 배양한 후, 배지를 제거하고 PBS를 넣고 자외선(UVB, 312 nm) 10mJ을 조사하였다. 이후, 25, 50 및 100㎍/㎖의 블랙커런트 기내배양묘 추출물을 처리하고 24시간 동안 배양한 후, 세포배양액을 회수하여 BCA 단백질 함량 측정 키트(Thermo scientific PIERCE, USA)를 이용하여 단백질을 정량한 후, MMP-1 ELISA 키트(sigma)를 이용하여 MMP-1의 발현양을 측정하였다. CCD-986SK cells were seeded on a 60mm plate at 4×10 5 cells/plate and cultured at 37°C, 5% CO 2 in an incubator for 24 hours, then the medium was removed, PBS was added, and UVB (UVB, 312 nm) 10mJ was applied. investigated. Then, 25, 50 and 100㎍ / ㎖ of blackcurrant in-flight seedling extracts were treated and cultured for 24 hours, the cell culture was recovered and the protein was quantified using a BCA protein content measurement kit (Thermo scientific PIERCE, USA). After that, the expression level of MMP-1 was measured using the MMP-1 ELISA kit (sigma).
그 결과, 아무것도 처리하지 않은 대조군 대비 블랙커런트 기내배양묘 추출물 처리군의 MMP-1 발현양이 감소한 것을 확인하였다. 특히, 50 및 100㎍/㎖의 블랙커런트 기내배양묘 추출물은 주름개선 성분으로 알려진 아데노신(adenosine)보다 MMP-1 발현 억제 효과가 우수한 것을 확인하였다(도 4).As a result, it was confirmed that the MMP-1 expression level of the blackcurrant in-flight seedling extract treatment group was decreased compared to the control group that was not treated with anything. In particular, it was confirmed that 50 and 100 μg/ml of in-flight cultured black currant seedling extract had a superior effect on inhibiting MMP-1 expression than adenosine, which is known as a wrinkle-improving component ( FIG. 4 ).
상기 결과를 통해, 블랙커런트 기내배양묘 추출물은 MMP-1의 발현을 감소시킴으로써, 피부 주름개선 활성이 있음을 알 수 있었다. Through the above results, it was found that the extract of blackcurrant in-flight seedlings had skin wrinkle improvement activity by reducing the expression of MMP-1.
[통계 처리][Statistics processing]
본 발명의 모든 데이터는 평균±표준오차로 표현하였으며, 데이터의 통계처리는 SPSS(Statistical Package for Social Science, Chicago, IL, USA)를 이용하여 분석하였다. 그룹 간에 일원배치 분산분석(one-way ANOVA)을 시행하였으며, 던컨분석(Duncan test)에 의하여 각 구간의 유의성을 판별하였으며, 평균값들에 대한 유의성은 신뢰수준 p<0.05에서 검증하였다.All data of the present invention were expressed as mean ± standard error, and statistical processing of the data was analyzed using SPSS (Statistical Package for Social Science, Chicago, IL, USA). One-way ANOVA was performed between groups, and the significance of each section was determined by Duncan test, and the significance of the mean values was verified at a confidence level of p<0.05.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210025759A KR20220121544A (en) | 2021-02-25 | 2021-02-25 | Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210025759A KR20220121544A (en) | 2021-02-25 | 2021-02-25 | Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220121544A true KR20220121544A (en) | 2022-09-01 |
Family
ID=83282221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210025759A KR20220121544A (en) | 2021-02-25 | 2021-02-25 | Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220121544A (en) |
-
2021
- 2021-02-25 KR KR1020210025759A patent/KR20220121544A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101997893B1 (en) | Method of increase the bioactive effectiveness of sprout ginseng | |
KR101828584B1 (en) | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening | |
JP4948044B2 (en) | Plaque formation inhibitor or anti-cariogenic agent | |
JP2021502953A (en) | Cosmetic composition for skin whitening and wrinkle improvement containing Centella asiatica extract as an active ingredient | |
KR101821024B1 (en) | COMPOSITION OF SKIN WHITENING CONTAINING EXTRACT OF Gloiopeltis Furcata AND METHOD OF MAKING THE SAME | |
JP2014005293A (en) | Skin external preparation composition including culture with rose placental tissue or its extract, method for producing the same, functional food and antioxidant composition | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR20160090098A (en) | Cosmetic composition using extract of seedpod of nelumbo nucifera containing plenty of polyphenol for anti-aging and whitening | |
KR101863117B1 (en) | Composition comprising Androsace umbellate extract, Vaccinium oldhami extract, and Deutzia crenata extract | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20220121544A (en) | Composition for anti-microbial and anti-wrinkle comprising extract of in vitro cultured plantlet of Black currant having antioxidant activity as effective component | |
KR20210134589A (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR101995384B1 (en) | Composition for skin whitening and anti-oxidation comprising fermented Gynura procumbens as effective component | |
KR20180024481A (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR101906245B1 (en) | Cosmetic composition for anti-oxidant and skin whitening effect comprising buckwheat seed extract of specific germination condition as effective component | |
KR101889492B1 (en) | composition containing complex extract of Morus alba for pendula, Prunus salicina and Oenothera lamarckiana | |
KR101761142B1 (en) | Skin-lightening Composition Using an Extract of Rumex acetosella | |
KR102561112B1 (en) | Antimicrobial composition comprising Hippocampus abdominalis extract as effective component | |
KR102406982B1 (en) | Composition for improving dermatitis comprising extract of Antennaria dioica having antioxidant activity as effective component | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component | |
KR102453568B1 (en) | Composition for moisturizing and anti-inflammation comprising fermented Codium fragile extract fermented by inoculating Bacillus safensis strain | |
KR102296938B1 (en) | Antioxidant composition comprising veronica longifolia | |
KR102561258B1 (en) | Composition for controlling sebum and improving pore comprising Jasminum Officinale, Salix Alba (willow) bark and Solanum melogena fruit extract | |
KR102448072B1 (en) | Composition for improving dermatitis comprising extract of Weigela subsessilis having antioxidant activity as effective component | |
KR102449136B1 (en) | Compositions containing Taraxacum coreanum extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |